Consortia are regional ISPOR groups comprised of chapters and individual ISPOR members in the region. The mission of consortia, consistent with the mission of the Society, is to advance health economics and outcomes research (HEOR) excellence to improve healthcare decision making in the region. ISPOR consortia includes:
The ISPOR Consortia leadership constitutes the ISPOR Global Engagement Council and participates in its activities.
Consortia are supported by various working committees, including:
The Consortium Executive Committee is the policy and decision making body of the Consortium.
The Consortium Publication Committee promotes the science of health economics and outcomes research in the region by producing the Consortium newsletters and working with ISPOR editors and staff in securing regional content for publication in Value in Health, Value in Health Regional Issues, and Value & Outcomes Spotlight.
Up to five additional Committees may be developed with ISPOR staff liaison support, presented in the Consortium Annual Agenda and approved by the ISPOR CEO & Executive Director. These Committees may include: Advisory, Industry, Research, and others as described below:
A strategic and technical advisory committee to the Consortium Executive Committee, the Advisory Committee provides counsel on new initiatives, health science or health policy issues, and other activities of the consortium.
The Consortium Industry Committee provides a global platform for industry members to discuss issues important to the health technology innovations and market development in the region.
The Consortia Education Committee encourages, facilitates, and promotes ISPOR educational programs in the region and supports information sharing within the Society on the educational activities of regional members.
The Research Committee designs and engages in projects that enhance the science of the HEOR (clinical, economic, and patient-reported outcomes) and lead to improvements in the healthcare system in the region. The committee facilitates the development and update of the Society's Global Health Care Systems Roadmap, Pharmacoeconomic Guidelines (where applicable), and is a contact point on the regional research questions for ISPOR inquiries.
Consortium members may participate in working committees. Contact us for more information.